Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Asmuth

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 1, 2006
Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384Rajesh T Gandhi, John Spritzler, Ellen Chan, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 26, 2005
Estimating cell death in G(2)M using bivariate BrdUrd/DNA flow cytometryR Allen White, David M Asmuth, Ying Lu, et al.
Pathogens & Immunity|May 30, 2019
Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ARTNetanya S Utay, Anoma Somasunderam, John E Hinkle, et al.
HIV Clinical Trials|December 7, 2017
Evaluation of oral serum-derived bovine immunoglobulins in HIV-infected patients with chronic idiopathic diarrheaDavid M Asmuth, John E Hinkle, Anthony LaMarca, et al.
Science (New York, N.Y.)|March 28, 2009
Quantitative 3D video microscopy of HIV transfer across T cell virological synapsesWolfgang Hübner, Gregory P McNerney, Ping Chen, et al.
HIV Clinical Trials|April 30, 2015
Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agentsJuergen K Rockstroh, Vicente Soriano, Frank Plonski, et al.
HIV Clinical Trials|January 19, 2016
Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiretroviral AgentsJùrgen K Rockstroch, Vicente Soriano, Frank Plonski, et al.
The Journal of Infectious Diseases|October 18, 2017
Associations of Plasma Cytokine and Microbial Translocation Biomarkers With Immune Reconstitution Inflammatory SyndromeVarghese George, Linda Harrison, Margaret Roach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2009
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384Gregory K Robbins, John G Spritzler, Ellen S Chan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2009
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjectsGail Skowron, John G Spritzler, Jodi Weidler, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Journal of Acquired Immune Deficiency Syndromes (1999)|July 1, 2006
Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384Rajesh T Gandhi, John Spritzler, Ellen Chan, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|May 26, 2005
Estimating cell death in G(2)M using bivariate BrdUrd/DNA flow cytometryR Allen White, David M Asmuth, Ying Lu, et al.
Pathogens & Immunity|May 30, 2019
Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ARTNetanya S Utay, Anoma Somasunderam, John E Hinkle, et al.
HIV Clinical Trials|December 7, 2017
Evaluation of oral serum-derived bovine immunoglobulins in HIV-infected patients with chronic idiopathic diarrheaDavid M Asmuth, John E Hinkle, Anthony LaMarca, et al.
Science (New York, N.Y.)|March 28, 2009
Quantitative 3D video microscopy of HIV transfer across T cell virological synapsesWolfgang Hübner, Gregory P McNerney, Ping Chen, et al.
HIV Clinical Trials|April 30, 2015
Hepatic safety in subjects with HIV-1 and hepatitis C and/or B virus: a randomized, double-blind study of maraviroc versus placebo in combination with antiretroviral agentsJuergen K Rockstroh, Vicente Soriano, Frank Plonski, et al.
HIV Clinical Trials|January 19, 2016
Corrigendum. Hepatic Safety in Subjects With HIV-1 and Hepatitis C and/or B Virus: A Randomised, Double-Blind Study of Maraviroc vs Placebo in Combination With Antiretroviral AgentsJùrgen K Rockstroch, Vicente Soriano, Frank Plonski, et al.
The Journal of Infectious Diseases|October 18, 2017
Associations of Plasma Cytokine and Microbial Translocation Biomarkers With Immune Reconstitution Inflammatory SyndromeVarghese George, Linda Harrison, Margaret Roach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2009
Incomplete reconstitution of T cell subsets on combination antiretroviral therapy in the AIDS Clinical Trials Group protocol 384Gregory K Robbins, John G Spritzler, Ellen S Chan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 6, 2009
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjectsGail Skowron, John G Spritzler, Jodi Weidler, et al.
Pageof 6